A new AI tool could slash cancer drug research waiting times in half - AI technology developed by a team at The Institute of ...
In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...
Ethan Grimes, BS, and Paul Morgan, MD, conduct rational drug design at the newly launched AI Small Molecule Drug Discovery Center at the Icahn School of Medicine at Mount Sinai. As part of Mount Sinai ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results